Skip to content

Study on the detection value of colorectal adenomas by different artificial intelligence-assisted diagnostic devices

Study on the detection value of colorectal adenomas by different artificial intelligence-assisted diagnostic devices(Eagle-Eye & ENDOANGEL )

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091641
Enrollment
Unknown
Registered
2024-10-31
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal adenomas

Interventions

Routine colonoscopy team:Blank control group
ENDOANGEL Assisted Colonoscopy Team:artificial intelligence-assisted diagnostic devices
Eagle-Eye Assisted Colonoscopy Team:artificial intelligence-assisted diagnostic devices

Sponsors

Shandong Second Provincial General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Age 18-75 years old, regardless of gender; 76-85 years old will be enrolled as appropriate according to the general condition of the subject. 2) People undergoing colonoscopy screening or physical examination 3) Signed informed consent

Exclusion criteria

Exclusion criteria: 1) Therapeutic colonoscopy patients with follow-up or confirmed polyps after polypectomy 2) Highly suspected or diagnosed colorectal cancer 3) Alarming symptoms or signs (blood in stool, dark stool, unexplained anemia and weight loss, abdominal mass, Positive rectal examination) 4) Pregnant or lactating women 5) Gastrointestinal obstruction 6) Inflammatory bowel disease, colon polyposis and serrated polyp syndrome. 7) People who have taken anticoagulants such as aspirin or warfarin within 7 days before the colonoscopy, or people with coagulation abnormalities. Those who are taking anticoagulants such as aspirin or warfarin within 7 days prior to the colonoscopy or have abnormal blood clotting 8) Participating in other clinical observation trials or participating in other clinical trials within 60 days. 9) Failure of insertion of the scope for any reason (obstruction of the scope, inability of the patient to tolerate the examination) or the colonoscope does not reach the cecum 10) Use of bowel preparation medications not recommended by guidelines such as magnesium sulfate, senna, etc. 11) Missing information on the CRF table Translated with www.DeepL.com/Translator (free version)

Design outcomes

Primary

MeasureTime frame
Adenoma detection rate;

Countries

China

Contacts

Public ContactWei Zhi

Shandong Second Provincial General Hospital

bj-1256@163.com+86 139 6915 6983

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026